SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Deutsch Corey

(Last) (First) (Middle)
C/O LIFEMD, INC.,
800 THIRD AVENUE, SUITE 2800

(Street)
NEW YORK, NY 10022

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/03/2021
3. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Business Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
02/05/2021
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 48,630(1)(2) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase shares of Common Stock(3) (4) (4) Common Stock, par value $0.001 25,000 (4) D(4)
Options to purchase shares of Common Stock (5) (5) Common Stock, par value $0.001 175,000 (5) D(5)
Explanation of Responses:
1. This Form 3 amendment is being filed to correct the number of shares directly owned Mr. Deutsch as of February 3, 2021.
2. Previously filed Form 3/A on April 29, 2021 was erroneously filed with a scriveners error related to the date Mr. Deutsch purchased such shares. The shares were purchased by Mr. Deutsch on November 19, 2020, in a private placement offering by the Company.
3. On February 3, 2021 (the "Effective Date"), Mr. Deutsch and the Issuer entered into First Amendment to Employment Agreement (the "Amended Employment Agreement"), whereby Mr. Deutsch was appointed Chief Business Officer of the Issuer. As of the Effective Date, the Board of Directors of the Issuer has acknowledged the role of Chief Business Officer as an executive officer position.
4. Pursuant to the terms of the consulting agreement, by and between Mr. Deutsch and the Issuer, dated December 3, 2020, Mr. Deutsch was granted stock options to purchase up to 25,000 shares of the Company's common stock at an exercise price of $8.25 per share (the "Consultancy Stock Options"). The Consultancy Stock Options vested on December 3, 2020.
5. Pursuant to the terms of the employment agreement, by and between Mr. Deutsch and the Issuer, dated January 14, 2021, Mr. Deutsch was granted stock options to purchase up to 175,000 shares of the Company's common stock at an exercise price of $7.07 per share (the "Stock Options"). The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36 months, beginning on the Effective Date.
/s/ Corey Deutsch 04/29/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.